Backdoor AI Beneficiary Yields 8.8%, Trades at 13% Discount

Backdoor AI Beneficiary Yields 8.8%, Trades at 13% Discount Drug development will never be the same! AI is compressing time-to-market and extending the sales calendar for pharma. More profits from new medications. More new medications, too. Many pharma and biotech stocks will boom as we enter the "sci-fi†stage of research and development. And this elite 8.8% dividend will directly benefit. It typically takes 10 to 15 years to develop a new drug. Every month matters because patents last only 20 years. The fa ...